During the past decade, Aurora Health Center-Fond du Lac conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 42 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 42 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora Health Center-Fond du Lac" #1 sponsor was "National Cancer Institute (NCI)" with 51 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Health Center-Fond du Lac" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Health Center-Fond du Lac" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Aurora Health Center-Fond du Lac" in a lesser frequency.

Most popular intervention types in "Aurora Health Center-Fond du Lac" are "Drug" (84 trials), "Other" (73 trials), "Biological" (40 trials), "Procedure" (27 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (29 trials), "Computed Tomography" (16 trials), "Nivolumab" (14 trials) and "Docetaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Health Center-Fond du Lac" are 83 trials for "All" genders, 25 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Aurora Health Center-Fond du Lac". undefined are not yet recruiting, 15 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Aurora Health Center-Fond du Lac, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Health Center-Fond du Lac, 3 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".